U.S. market Closed. Opens in 1 day 16 hours 16 minutes

ONCY | Oncolytics Biotech Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A4.85MN/AN/AN/AN/AN/AN/A783.46K699.76K313.31K208.87KN/A310.00K1.00
Cost of Revenue403.00K392.00K452.06K446.19K485.57K95.38K90.77K162.23K180.41KN/AN/A4.85M5.33M4.19M3.78M4.31MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-403.00K-392.00K-452.06K-446.19K-485.57K-95.38K-90.77K-162.23K-180.41KN/AN/AN/A-5.33M-4.19M-3.78M-4.31MN/AN/A783.46K699.76K313.31K208.87KN/A310.00K1.00
Operating Expenses33.79M26.92M26.23M25.46M20.69M16.66M15.61M15.29M13.92M18.82M23.90M36.69M28.72M15.51M17.00M13.76M16.85M15.50M13.31M13.33M6.93M6.96M7.14M4.96M577.37K
Selling, General & Admin16.08M11.49M12.86M12.07M8.84M7.08M6.21M5.36M5.14M5.00M372.74K730.75K1.14M3.25M4.40M64.04K4.53M4.03M3.15M5.47M2.95M2.10M1.56M1.06M89.03K
Research & Development17.71M15.43M12.92M12.94M11.13M9.42M9.39M9.77M8.60M13.82M18.51M31.40M23.39M12.19M12.15M13.35M11.32M10.54M9.31M7.11M3.31M4.28M5.12M3.69M486.66K
Other Operating ExpensesN/AN/A13.31M12.51M9.56M7.24M6.21M162.23K180.41K5.00M5.02M4.55MN/A409.84K425.40K341.97K5.53M4.96M4.00M6.22M3.62M2.68M2.02M1.27M90.71K
Operating Income-33.79M-28.57M-26.23M-25.46M-20.69M-16.66M-15.61M-15.29M-13.92M-18.82M-23.90M-36.69M-28.72M-20.04M-17.00M-18.07M-16.85M-15.50M-12.53M-12.63M-6.62M-6.75M-7.14M-4.65M-577.37K
Other Expenses / Income6.14M2.17M-20.05K2.95M-12.43M173.50K130.10K163.90K197.86K210.39K371.49K345.00K-283.43K76.93K30.83K519.26K1.20M1.20M529.09K-323.88K-1.89MN/A655.21K905.69KN/A
Before Tax Income-27.66M-24.75M-26.25M-22.51M-33.12M-16.49M-15.48M-15.13M-13.72M-18.61M-23.53M-36.34M-29.00M-19.97M-16.97M-17.55M-15.64M-14.30M-12.78M-12.96M-8.51M-6.75M-6.48M-3.74MN/A
Income Tax Expenses97.00K84.00K49.43K-2.95M12.43M548.04K141.50K9.37K3.15K6.78K5.41K30.47K40.00K7.61K23.04KN/A-1.20M-1.20M-1.52K323.88K33.55K-659.90K-310.57K-126.81K-2.91K
Net Income-27.75M-24.84M-26.30M-19.55M-45.55M-17.04M-15.62M-15.14M-13.72M-18.62M-23.53M-36.37M-29.04M-19.97M-17.00M-17.55M-15.64M-14.30M-12.78M-12.96M-8.54M-6.09M-6.17M-3.61M-574.46K
Interest ExpensesN/A528.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding67.62M58.03M53.51M40.34M22.14M16.02M13.94M12.62M11.85M9.25M8.79M8.01M7.46M6.58M5.20M4.35M4.26M3.82M3.44M3.01M2.45M2.23M1.95M1.73M616.48K
Diluted Shares Outstanding67.62M58.03M53.51M40.34M22.14M16.02M13.94M12.62M11.85M9.25M8.79M8.01M7.46M6.58M5.20M4.35M4.26M3.82M3.44M3.01M2.45M2.23M1.95M1.83M616.48K
EBITDA-33.71M-26.83M-25.66M-25.37M-20.02M-17.18M-15.51M-15.13M-13.74M-18.66M-23.77M-36.58M-27.93M-19.29M-16.75M-17.66M-15.83M-14.53M-12.46M-12.58M-5.95M-6.18M-6.67M-4.44M-575.69K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-753.96%0.00%0.00%0.00%0.00%0.00%0.00%-1,589.94%-1,797.80%-1,900.62%-2,957.46%0.00%-1,432.41%-57,569,100.00%
EBIT-27.66M-24.22M-26.25M-22.51M-33.12M-16.49M-15.48M-15.13M-13.72M-18.61M-23.53M-36.34M-29.00M-19.97M-16.97M-17.55M-16.85M-15.50M-12.78M-12.63M-8.51M-6.75M-6.48M-3.74M-577.37K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-749.11%0.00%0.00%0.00%0.00%0.00%0.00%-1,631.66%-1,805.23%-2,716.36%-3,232.38%0.00%-1,206.44%-57,737,000.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙